Palmitic acid: Physiological role, metabolism and nutritional implications

Frontiers in Physiology

Volumn 8, Issue NOV, 2017, Pages

  Carta, Gianfranca ^a   Murru, Elisabetta ^a   Banni, Sebastiano ^a   Manca, Claudia ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

De novo lipogenesis; Lung surfactant; Palmitic acid; Palmitoylethanolamide; Protein palmitoylation

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ANANDAMIDE; CARBOHYDRATE DERIVATIVE; CD36 ANTIGEN; DIPALMITOYLPHOSPHATIDYLCHOLINE; FATTY ACID SYNTHASE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LUNG SURFACTANT; MONOUNSATURATED FATTY ACID; N ACYLETHANOLAMIDE; N ACYLETHANOLAMINE HYDROLYZING ACID AMIDASE; N PALMITOYLPHOSPHATIDYLETHANOLAMINE; PALMIDROL; PALMITIC ACID; PALMITOYL COENZYME A; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SPHINGOMYELIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANAEROBIC GLYCOLYSIS; BIOLOGICAL ACTIVITY; CARBOHYDRATE INTAKE; CARBOHYDRATE METABOLISM; CELL MEMBRANE; DYSLIPIDEMIA; ENERGY BALANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY ACID METABOLISM; HUMAN; HYPERGLYCEMIA; LIPID STORAGE; LIPOGENESIS; MALIGNANT NEOPLASM; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITION; OBESITY; PALMITOYLATION; PATHOPHYSIOLOGY; PROTEIN PALMITOYLATION; REVIEW; SEDENTARY LIFESTYLE;

EID: 85033562059     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2017.00902     Document Type: Review

References (194)

1. Abbott, S. K., Else, P. L., Atkins, T. A., and Hulbert, A. J. (2012). Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance. Biochim. Biophys. Acta 1818, 1309-1317. doi: 10.1016/j.bbamem.2012.01.011
2. Ainsworth, S. B., and Milligan, D. W. (2002). Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review. Am. J. Respir. Med. 1, 417-433. doi: 10.1007/BF03257169
3. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2002). Molecular Biology of the Cell, 4th Edn. New York, NY: Garland Science
4. Ambrosino, P., Soldovieri, M. V., Russo, C., and Taglialatela, M. (2013). Activation and desensitization of TRPV1 channels in sensory neurons by the PPARalpha agonist palmitoylethanolamide. Br. J. Pharmacol. 168, 1430-1444. doi: 10.1111/bph.12029
5. Avery, M. E., and Mead, J. (1959). Surface properties in relation to atelectasis and hyaline membrane disease. AMA J. Dis. Child 97(5, Pt 1), 517-523. doi: 10.1001/archpedi.1959.02070010519001
6. Baekkeskov, S., and Kanaani, J. (2009). Palmitoylation cycles and regulation of protein function (Review). Mol. Membr. Biol. 26, 42-54. doi: 10.1080/09687680802680108
7. Baillie, A. G., Coburn, C. T., and Abumrad, N. A. (1996). Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J. Membr. Biol. 153, 75-81. doi: 10.1007/s002329900111
8. Balvers, M. G., Verhoeckx, K. C., Meijerink, J., Bijlsma, S., Rubingh, C. M., Wortelboer, H. M., et al. (2012). Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum and adipose tissue in C57BL/6 mice fed a fish-oil diet. Int. Immunopharmacol. 13, 204-214. doi: 10.1016/j.intimp.2012.03.022
9. Banni, S., Carta, G., Murru, E., Cordeddu, L., Giordano, E., Sirigu, A. R., et al. (2011). Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr. Metab. (Lond). 8, 7. doi: 10.1186/1743-7075-8-7
10. Baritussio, A., Enzi, G., Inelmen, E. M., Schiavon, M., de Biasi, F., Allegra, L., et al. (1980). Altered surfactant synthesis and function in rats with diet-induced hyperlipidemia. Metabolism 29, 503-510. doi: 10.1016/0026-0495(80)90075-X
11. Baritussio, A., Enzi, G., Rigon, G., Molinari, M., Inelmen, E. M., and Crepaldi, G. (1978). Effect of anorexiant drugs on growth hormone secretion in obese children. Pharmacol. Res. Commun. 10, 529-540. doi: 10.1016/S0031-6989(78)80051-4
12. Bassett, J. K., Hodge, A. M., English, D. R., MacInnis, R. J., and Giles, G. G. (2016). Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk. Cancer Causes Control 27, 759-773. doi: 10.1007/s10552-016-0753-2
13. Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., Vogel, Z., et al. (1998). An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 353, 23-31. doi: 10.1016/S0014-2999(98)00392-6
14. Bergman, B. C., Perreault, L., Hunerdosse, D. M., Koehler, M. C., Samek, A. M., and Eckel, R. H. (2010). Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes. J. Appl. Physiol. (1985) 108, 1134-1141. doi: 10.1152/japplphysiol.00684.2009
15. Biolchini, M., Murru, E., Anfora, G., Loy, F., Banni, S., Crnjar, R., et al. (2017). Fat storage in Drosophila suzukii is influenced by different dietary sugars in relation to their palatability. PLoS ONE 12:e0183173. doi: 10.1371/journal.pone.0183173
16. Bisogno, T. (2008). Endogenous cannabinoids: structure and metabolism. J. Neuroendocrinol. 20(Suppl. 1), 1-9. doi: 10.1111/j.1365-2826.2008.01676.x
17. Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., and Di Marzo, V. (1997). Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 272, 3315-3323. doi: 10.1074/jbc.272.6.3315
18. Blancaflor, E. B., Kilaru, A., Keereetaweep, J., Khan, B. R., Faure, L., and Chapman, K. D. (2014). N-Acylethanolamines: lipid metabolites with functions in plant growth and development. Plant J. 79, 568-583. doi: 10.1111/tpj.12427
19. Blaskovic, S., Blanc, M., and van der Goot, F. G. (2013). What does S-palmitoylation do to membrane proteins? FEBS J. 280, 2766-2774. doi: 10.1111/febs.12263
20. Bojesen, I. N., and Hansen, H. S. (2003). Binding of anandamide to bovine serum albumin. J. Lipid Res. 44, 1790-1794. doi: 10.1194/jlr.M300170-JLR200
21. Bojesen, I. N., and Hansen, H. S. (2005). Membrane transport of anandamide through resealed human red blood cell membranes. J. Lipid Res. 46, 1652-1659. doi: 10.1194/jlr.M400498-JLR200
22. Brookheart, R. T., Michel, C. I., and Schaffer, J. E. (2009). As a matter of fat. Cell Metab. 10, 9-12. doi: 10.1016/j.cmet.2009.03.011
23. Burdge, G. C. (2006). Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 75, 161-168. doi: 10.1016/j.plefa.2006.05.013
24. Calder, P. C., and Yaqoob, P. (2007). Lipid rafts-composition, characterization, and controversies. J. Nutr. 137, 545-547
25. Calignano, A., La Rana, G., and Piomelli, D. (2001). Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 419, 191-198. doi: 10.1016/S0014-2999(01)00988-8
26. Calle, E. E., and Kaaks, R. (2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591. doi: 10.1038/nrc1408
27. Cao, H., Gerhold, K., Mayers, J. R., Wiest, M. M., Watkins, S. M., and Hotamisligil, G. S. (2008). Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933-944. doi: 10.1016/j.cell.2008.07.048
28. Carta, G., Melis, M., Pintus, S., Pintus, P., Piras, C. A., Muredda, L., et al. (2017). Participants with normal weight or with obesity show different relationships of 6-n-Propylthiouracil (PROP) taster status with BMI and plasma endocannabinoids. Sci. Rep. 7:1361. doi: 10.1038/s41598-017-01562-1
29. Carta, G., Murru, E., Lisai, S., Sirigu, A., Piras, A., Collu, M., et al. (2015). Dietary triacylglycerols with palmitic acid in the sn-2 position modulate levels of N-acylethanolamides in rat tissues. PLoS ONE 10:e0120424. doi: 10.1371/journal.pone.0120424
30. Chakravarthy, M. V., Lodhi, I. J., Yin, L., Malapaka, R. R., Xu, H. E., Turk, J., et al. (2009). Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 138, 476-488. doi: 10.1016/j.cell.2009.05.036
31. Chong, M. F., Hodson, L., Bickerton, A. S., Roberts, R., Neville, M., Karpe, F., et al. (2008). Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after3dof high-carbohydrate feeding. Am. J. Clin. Nutr. 87:7
32. Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., et al. (2008). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233. doi: 10.1038/nature06734
33. Clamp, A. G., Ladha, S., Clark, D. C., Grimble, R. F., and Lund, E. K. (1997). The influence of dietary lipids on the composition and membrane fluidity of rat hepatocyte plasma membrane. Lipids 32, 179-184. doi: 10.1007/s11745-997-0022-3
34. Clugston, R. D., Yuen, J. J., Hu, Y. Y., Abumrad, N. A., Berk, P. D., Goldberg, I. J., et al. (2014). CD36-deficient mice are resistant to alcohol-and high-carbohydrate-induced hepatic steatosis. J. Lipid Res. 55, 239-246. doi: 10.1194/jlr.M041863
35. Cnop, M., Foufelle, F., and Velloso, L. A. (2012). Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 18, 59-68. doi: 10.1016/j.molmed.2011.07.010
36. Cockshutt, A. M., and Possmayer, F. (1992). "Metabolism of surfactant lipids and proteins in the developing lung". in Pulmonary Surfactant: From Molecular Biology to Clinical Practice, eds B. Robertson, L. M. G. van Golde, and J. J. Batenburg (Amsterdam: Elsevier Science Publishers), 339-378
37. Cohen, J. C., Horton, J. D., and Hobbs, H. H. (2011). Human fatty liver disease: old questions and new insights. Science 332:6. doi: 10.1126/science.1204265
38. Collins, J. M., Neville, M. J., Hoppa, M. B., and Frayn, K. N. (2010). De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J. Biol. Chem. 285, 6044-6052. doi: 10.1074/jbc.M109.053280
39. Conti, S., Costa, B., Colleoni, M., Parolaro, D., and Giagnoni, G. (2002). Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol. 135, 181-187. doi: 10.1038/sj.bjp.0704466
40. Costa, B., Comelli, F., Bettoni, I., Colleoni, M., and Giagnoni, G. (2008). The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain 139, 541-550. doi: 10.1016/j.pain.2008.06.003
41. Crane, J. M., Bennett, J. L., and Verkman, A. S. (2009). Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells. J. Biol. Chem. 284, 35850-35860. doi: 10.1074/jbc.M109.071670
42. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., and Gilula, N. B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87. doi: 10.1038/384083a0
43. Creuwels, L. A., van Golde, L. M., and Haagsman, H. P. (1997). The pulmonary surfactant system: biochemical and clinical aspects. Lung 175, 1-39. doi: 10.1007/PL00007554
44. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20. doi: 10.1016/j.cmet.2007.10.002
45. De Petrocellis, L., Davis, J. B., and Di Marzo, V. (2001a). Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett. 506, 253-256. doi: 10.1016/S0014-5793(01)02934-9
46. De Petrocellis, L., Harrison, S., Bisogno, T., Tognetto, M., Brandi, I., Smith, G. D., et al. (2001b). The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem. 77, 1660-1663. doi: 10.1046/j.1471-4159.2001.00406.x
47. Di Marzo, V., Griinari, M., Carta, G., Murru, E., Ligresti, A., Cordeddu, L., et al. (2010). Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int. Dairy J. 20, 231-235. doi: 10.1016/j.idairyj.2009.11.015
48. Di Marzo, V., Melck, D., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., et al. (2001). Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem. J. 358(Pt 1), 249-255. doi: 10.1042/bj3580249
49. Dobrosotskaya, I. Y., Seegmiller, A. C., Brown, M. S., Goldstein, J. L., and Rawson, R. B. (2002). Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 296, 879-883. doi: 10.1126/science.1071124
50. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351. doi: 10.1172/JCI23621
51. Du, K., Murakami, S., Sun, Y., Kilpatrick, C. L., and Luscher, B. (2017). DHHC7 palmitoylates glucose transporter 4 (Glut4) and regulates glut4 membrane translocation. J. Biol. Chem. 292, 2979-2991. doi: 10.1074/jbc.M116.747139
52. Ellingson, W. J., Chesser, D. G., and Winder, W. W. (2007). Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25. Am. J. Physiol. Endocrinol. Metab. 292, E400-E407. doi: 10.1152/ajpendo.00322.2006
53. Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., and Klein, S. (2008). Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134, 424-431. doi: 10.1053/j.gastro.2007.11.038
54. Faergeman, N. J., and Knudsen, J. (1997). Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 323(Pt 1), 1-12. doi: 10.1042/bj3230001
55. Fantin, V. R., St-Pierre, J., and Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434. doi: 10.1016/j.ccr.2006.04.023
56. Feller, S. E. (2008). Acyl chain conformations in phospholipid bilayers: a comparative study of docosahexaenoic acid and saturated fatty acids. Chem. Phys. Lipids 153, 76-80. doi: 10.1016/j.chemphyslip.2008.02.013
57. Feller, S. E., Gawrisch, K., and MacKerell, A. D. Jr. (2002). Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. J. Am. Chem. Soc. 124, 318-326. doi: 10.1021/ja0118340
58. Friedman, Z. (1979). Polyunsaturated fatty acids in the low-birth-weight infant. Semin. Perinatol. 3, 341-361
59. Friedman, Z., and Rosenberg, A. (1979). Abnormal lung surfactant related to essential fatty acid deficiency in a neonate. Pediatrics 63, 855-859
60. Fukata, Y., and Fukata, M. (2010). Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 11, 161-175. doi: 10.1038/nrn2788
61. Giron-Calle, J., Schmid, P. C., and Schmid, H. H. (1997). Effects of oxidative stress on glycerolipid acyl turnover in rat hepatocytes. Lipids 32, 917-923. doi: 10.1007/s11745-997-0118-9
62. Goerke, J. (1974). Lung surfactant. Biochim. Biophys. Acta 344, 241-261. doi: 10.1016/0304-4157(74)90009-4
63. Goerke, J., and Clements, J. A. (1986). Alveolar Surface Tension and Lung Surfactant. Bethesda: American Physiological Society
64. Goerke, J., and Gonzales, J. (1981). Temperature dependence of dipalmitoyl phosphatidylcholine monolayer stability. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 51, 1108-1114
65. Greaves, J., and Chamberlain, L. H. (2007). Palmitoylation-dependent protein sorting. J. Cell Biol. 176, 249-254. doi: 10.1083/jcb.200610151
66. Guardiola-Serrano, F., Rossin, A., Cahuzac, N., Lückerath, K., Melzer, I., Mailfert, S., et al. (2010). Palmitoylation of human FasL modulates its cell death-inducing function. Cell Death Dis. 1:e88. doi: 10.1038/cddis.2010.62
67. Günther, A., Schmidt, R., Nix, F., Yabut-Perez, M., Guth, C., Rosseau, S., et al. (1999). Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur. Respir. J. 14, 565-573. doi: 10.1034/j.1399-3003.1999.14c14.x
68. Hallman, M., Enhorning, G., and Possmayer, F. (1985). Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr. Res. 19, 286-292. doi: 10.1203/00006450-198503000-00006
69. Hansen, H. S. (2013). Effect of diet on tissue levels of palmitoylethanolamide. CNS Neurol. Disord. Drug Targets 12, 17-25. doi: 10.2174/1871527311312010006
70. Hawco, M. W., Davis, P. J., and Keough, K. M. (1981). Lipid fluidity in lung surfactant: monolayers of saturated and unsaturated lecithins. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 51, 509-515
71. Henis, Y. I., Hancock, J. F., and Prior, I. A. (2009). Ras acylation, compartmentalization and signaling nanoclusters (Review). Mol. Membr. Biol. 26, 80-92. doi: 10.1080/09687680802649582
72. Hook, G. E. (1991). Alveolar proteinosis and phospholipidoses of the lungs. Toxicol. Pathol. 19(4 Pt 1), 482-513
73. Hopkins, D. T., Witter, R. L., and Nesheim, M. C. (1963). A respiratory disease syndrome in chickens fed essential fatty acid deficient diets. Proc. Soc. Exp. Biol. Med. 114, 82-86. doi: 10.3181/00379727-114-28592
74. Horton, J. D., Goldstein, J. L., and Brown, M. S. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131. doi: 10.1172/JCI0215593
75. Hubbard, V. S., Dunn, G. D., and di Sant'Agnese, P. A. (1977). Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect? Lancet 2, 1302-1304. doi: 10.1016/S0140-6736(77)90359-2
76. Hulbert, A. J., Kelly, M. A., and Abbott, S. K. (2014). Polyunsaturated fats, membrane lipids and animal longevity. J. Comp. Physiol. B 184, 149-166. doi: 10.1007/s00360-013-0786-8
77. Hulbert, A. J., Turner, N., Storlien, L. H., and Else, P. L. (2005). Dietary fats and membrane function: implications for metabolism and disease. Biol. Rev. Camb. Philos. Soc. 80, 155-169. doi: 10.1017/S1464793104006578
78. Hulver, M. W., Berggren, J. R., Carper, M. J., Miyazaki, M., Ntambi, J. M., Hoffman, E. P., et al. (2005). Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2, 251-261. doi: 10.1016/j.cmet.2005.09.002
79. Iannotti, F. A., Di Marzo, V., and Petrosino, S. (2016). Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders. Prog. Lipid Res. 62, 107-128. doi: 10.1016/j.plipres.2016.02.002
80. Innis, S. M. (2016). Palmitic acid in early human development. Crit. Rev. Food Sci. Nutr. 56, 1952-1959. doi: 10.1080/10408398.2015.1018045
81. Innis, S. M., and Dyer, R. (1997). Dietary triacylglycerols with palmitic acid (16:0) in the 2-position increase 16:0 in the 2-position of plasma and chylomicron triacylglycerols, but reduce phospholipid arachidonic and docosahexaenoic acids, and alter cholesteryl ester metabolism in formula-Fed piglets. J. Nutr. 127, 1311-1319
82. Izyumov, D. S., Avetisyan, A. V., Pletjushkina, O. Y., Sakharov, D. V., Wirtz, K. W., Chernyak, B. V., et al. (2004). "Wages of fear": transient threefold decrease in intracellular ATP level imposes apoptosis. Biochim. Biophys. Acta 1658, 141-147. doi: 10.1016/j.bbabio.2004.05.007
83. Jacobsson, S. O., and Fowler, C. J. (2001). Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br. J. Pharmacol. 132, 1743-1754. doi: 10.1038/sj.bjp.0704029
84. Jeffries, O., Geiger, N., Rowe, I. C., Tian, L., McClafferty, H., Chen, L., et al. (2010). Palmitoylation of the S0-S1 linker regulates cell surface expression of voltage-and calcium-activated potassium (BK) channels. J. Biol. Chem. 285, 33307-33314. doi: 10.1074/jbc.M110.153940
85. Jobe, A. H., and Ikegami, M. (2001). Biology of surfactant. Clin. Perinatol. 28, 655-669, vii-viii. doi: 10.1016/S0095-5108(05)70111-1
86. Jobe, A., and Ikegami, M. (1987). Surfactant for the treatment of respiratory distress syndrome. Am. Rev. Respir. Dis. 136, 1256-1275. doi: 10.1164/ajrccm/136.5.1256
87. Joseph, M., and Nagaraj, R. (1995). Interaction of peptides corresponding to fatty acylation sites in proteins with model membranes. J. Biol. Chem. 270, 16749-16755. doi: 10.1074/jbc.270.28.16749
88. Kaczocha, M., Vivieca, S., Sun, J., Glaser, S. T., and Deutsch, D. G. (2012). Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J. Biol. Chem. 287, 3415-3424. doi: 10.1074/jbc.M111.304907
89. Kahn, M. C., Anderson, G. J., Anyan, W. R., and Hall, S. B. (1995). Phosphatidylcholine molecular species of calf lung surfactant. Am. J. Physiol. 269(5 Pt 1), L567-L573
90. Kapur, A., Zhao, P., Sharir, H., Bai, Y., Caron, M. G., Barak, L. S., et al. (2009). Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J. Biol. Chem. 284, 29817-29827. doi: 10.1074/jbc.M109.050187
91. King, R. J. (1984). Lipid-apolipoprotein interactions in surfactant studied by reassembly. Exp. Lung Res. 6, 237-253. doi: 10.3109/01902148409109251
92. Kyriakides, E. C., Beeler, D. A., Edmonds, R. H., and Balint, J. A. (1976). Alterations in phosphatidylcholine species and their reversal in pulmonary surfactant during essential fatty-acid deficiency. Biochim. Biophys. Acta 431, 399-407. doi: 10.1016/0005-2760(76)90206-X
93. Lakkaraju, A. K., Abrami, L., Lemmin, T., Blaskovic, S., Kunz, B., Kihara, A., et al. (2012). Palmitoylated calnexin is a key component of the ribosome-translocon complex. EMBO J. 31, 1823-1835. doi: 10.1038/emboj.2012.15
94. Lambert, D. M., and Di Marzo, V. (1999). The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr. Med. Chem. 6, 757-773
95. Lambert, J. E., Ramos-Roman, M. A., Browning, J. D., and Parks, E. J. (2014). Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726-735. doi: 10.1053/j.gastro.2013.11.049
96. Lang, C. J., Postle, A. D., Orgeig, S., Possmayer, F., Bernhard, W., Panda, A. K., et al. (2005). Dipalmitoylphosphatidylcholine is not the major surfactant phospholipid species in all mammals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R1426-R1439. doi: 10.1152/ajpregu.00496.2004
97. Lee, J. J., Lambert, J. E., Hovhannisyan, Y., Ramos-Roman, M. A., Trombold, J. R., Wagner, D. A., et al. (2015). Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am. J. Clin. Nutr. 101, 34-43. doi: 10.3945/ajcn.114.092262
98. Levental, I., Lingwood, D., Grzybek, M., Coskun, U., and Simons, K. (2010). Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. U.S.A. 107, 22050-22054. doi: 10.1073/pnas.1016184107
99. Li, P., Banjade, S., Cheng, H. C., Kim, S., Chen, B., Guo, L., et al. (2012). Phase transitions in the assembly of multivalent signalling proteins. Nature 483, 336-340. doi: 10.1038/nature10879
100. Linder, M. E., and Deschenes, R. J. (2007). Palmitoylation: policing protein stability and traffic. Nat. Rev. Mol. Cell Biol. 8, 74-84. doi: 10.1038/nrm2084
101. Liu, R., Wang, D., Shi, Q., Fu, Q., Hizon, S., and Xiang, Y. K. (2012). Palmitoylation regulates intracellular trafficking of beta2 adrenergic receptor/arrestin/phosphodiesterase 4D complexes in cardiomyocytes. PLoS ONE 7:e42658. doi: 10.1371/journal.pone.0042658
102. Lombard, J., López-García, P., and Moreira, D. (2012). The early evolution of lipid membranes and the three domains of life. Nat. Rev. Microbiol. 10, 507-515. doi: 10.1038/nrmicro2815
103. Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., et al. (2005). The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67, 15-19. doi: 10.1124/mol.104.006353
104. Lu, W., and Roche, K. W. (2012). Posttranslational regulation of AMPA receptor trafficking and function. Curr. Opin. Neurobiol. 22, 470-479. doi: 10.1016/j.conb.2011.09.008
105. Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., et al. (2016). NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531, 253-257. doi: 10.1038/nature16969
106. Maeda, A., Okano, K., Park, P. S., Lem, J., Crouch, R. K., Maeda, T., et al. (2010). Palmitoylation stabilizes unliganded rod opsin. Proc. Natl. Acad. Sci. U.S.A. 107, 8428-8433. doi: 10.1073/pnas.1000640107
107. Marques-Lopes, I., Ansorena, D., Astiasaran, I., Forga, L., and Martínez, J. A. (2001). Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am. J. Clin. Nutr. 73:9
108. Martin, B. R., and Cravatt, B. F. (2009). Large-scale profiling of protein palmitoylation in mammalian cells. Nat. Methods 6, 135-138. doi: 10.1038/nmeth.1293
109. Matias, I., Carta, G., Murru, E., Petrosino, S., Banni, S., and Di Marzo, V. (2008). Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim. Biophys. Acta 1781, 52-60. doi: 10.1016/j.bbalip.2007.11.001
110. Meckler, X., Roseman, J., Das, P., Cheng, H., Pei, S., Keat, M., et al. (2010). Reduced Alzheimer's disease ss-amyloid deposition in transgenic mice expressing S-palmitoylation-deficient APH1aL and nicastrin. J. Neurosci. 30, 16160-16169. doi: 10.1523/JNEUROSCI.4436-10.2010
111. Melkonian, K. A., Ostermeyer, A. G., Chen, J. Z., Roth, M. G., and Brown, D. A. (1999). Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274, 3910-3917. doi: 10.1074/jbc.274.6.3910
112. Menendez, J. A., and Lupu, R. (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763-777. doi: 10.1038/nrc2222
113. Merrick, B. A., Dhungana, S., Williams, J. G., Aloor, J. J., Peddada, S., Tomer, K. B., et al. (2011). Proteomic profiling of S-acylated macrophage proteins identifies a role for palmitoylation in mitochondrial targeting of phospholipid scramblase 3. Mol. Cell. Proteomics 10:M110 006007. doi: 10.1074/mcp.M110.006007
114. Moreno-Sánchez, R., Rodríguez-Enríquez, S., Marín-Hernández, A., and Saavedra, E. (2007). Energy metabolism in tumor cells. FEBS J. 274, 1393-1418. doi: 10.1111/j.1742-4658.2007.05686.x
115. Motoki, K., Kume, H., Oda, A., Tamaoka, A., Hosaka, A., Kametani, F., et al. (2012). Neuronal beta-amyloid generation is independent of lipid raft association of beta-secretase BACE1: analysis with a palmitoylation-deficient mutant. Brain Behav. 2, 270-282. doi: 10.1002/brb3.52
116. Mueller, G. M., Maarouf, A. B., Kinlough, C. L., Sheng, N., Kashlan, O. B., Okumura, S., et al. (2010). Cys palmitoylation of the beta subunit modulates gating of the epithelial sodium channel. J. Biol. Chem. 285, 30453-30462. doi: 10.1074/jbc.M110.151845
117. Nohara, K., Berggren, P., Curstedt, T., Grossmann, G., Nilsson, R., and Robertson, B. (1986). Correlations between physical and physiological properties of various preparations of lung surfactant. Eur. J. Respir. Dis. 69, 321-335
118. Notter, R. H., and Finkelstein, J. N. (1984). Pulmonary surfactant: an interdisciplinary approach. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 57, 1613-1624
119. Ntambi, J. M. (1995). The regulation of stearoyl-CoA desaturase (SCD). Prog. Lipid Res. 34, 139-150. doi: 10.1016/0163-7827(94)00010-J
120. Ntambi, J. M. (1999). Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40, 1549-1558
121. Numata, M., Chu, H. W., Dakhama, A., and Voelker, D. R. (2010). Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc. Natl. Acad. Sci. U.S.A. 107, 320-325. doi: 10.1073/pnas.0909361107
122. Oddi, S., Dainese, E., Sandiford, S., Fezza, F., Lanuti, M., Chiurchiu, V., et al. (2012). Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. Br. J. Pharmacol. 165, 2635-2651. doi: 10.1111/j.1476-5381.2011.01658.x
123. Oddi, S., Fezza, F., Pasquariello, N., D'Agostino, A., Catanzaro, G., De Simone, C., et al. (2009). Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chem. Biol. 16, 624-632. doi: 10.1016/j.chembiol.2009.05.004
124. Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Batkai, S., et al. (2005). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115, 1298-1305. doi: 10.1172/JCI200523057
125. Pala, V., Krogh, V., Muti, P., Chajes, V., Riboli, E., Micheli, A., et al. (2001). Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J. Natl. Cancer Inst. 93, 1088-1095. doi: 10.1093/jnci/93.14.1088
126. Palombo, J. D., Lydon, E. E., Chen, P. L., Bistrian, B. R., and Forse, R. A. (1994). Fatty acid composition of lung, macrophage and surfactant phospholipids after short-term enteral feeding with n-3 lipids. Lipids 29, 643-649. doi: 10.1007/BF02536099
127. Pamplona, R. (2008). Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity. Biochim. Biophys. Acta 1777, 1249-1262. doi: 10.1016/j.bbabio.2008.07.003
128. Pascual, G., Avgustinova, A., Mejetta, S., Martin, M., Castellanos, A., Attolini, C. S., et al. (2017). Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41-45. doi: 10.1038/nature20791
129. Pepino, M. Y., Kuda, O., Samovski, D., and Abumrad, N. A. (2014). Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. Annu. Rev. Nutr. 34, 281-303. doi: 10.1146/annurev-nutr-071812-161220
130. Peter, A., Weigert, C., Staiger, H., Machicao, F., Schick, F., Machann, J., et al. (2009). Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58, 1757-1765. doi: 10.2337/db09-0188
131. Petrosino, S., and Di Marzo, V. (2017). The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br. J. Pharmacol. 174, 1349-1365. doi: 10.1111/bph.13580
132. Petrosino, S., Schiano Moriello, A., Cerrato, S., Fusco, M., Puigdemont, A., De Petrocellis, L., et al. (2016). The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. Br. J. Pharmacol. 173, 1154-1162. doi: 10.1111/bph.13084
133. Pinnamaneni, S. K., Southgate, R. J., Febbraio, M. A., and Watt, M. J. (2006). Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 49, 3027-3037. doi: 10.1007/s00125-006-0427-9
134. Piras, A., Carta, G., Murru, E., Lopes, P. A., Martins, S. V., Prates, J. A., et al. (2015). Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats. Prostaglandins Leukot. Essent. Fatty Acids 98, 15-19. doi: 10.1016/j.plefa.2015.04.004
135. Piscitelli, F., Carta, G., Bisogno, T., Murru, E., Cordeddu, L., Berge, K., et al. (2011). Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr. Metab. (Lond). 8:51. doi: 10.1186/1743-7075-8-51
136. Pollak, M. (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8, 915-928. doi: 10.1038/nrc2536
137. Possmayer, F. (1988). A proposed nomenclature for pulmonary surfactant-associated proteins. Am. Rev. Respir. Dis. 138, 990-998. doi: 10.1164/ajrccm/138.4.990
138. Possmayer, F., Yu, S. H., Weber, J. M., and Harding, P. G. (1984). Pulmonary surfactant. Can. J. Biochem. Cell Biol. 62, 1121-1133. doi: 10.1139/o84-146
139. Re, G., Barbero, R., Miolo, A., and Di Marzo, V. (2007). Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet. J. 173, 21-30. doi: 10.1016/j.tvjl.2005.10.003
140. Robertson, B., and Lachmann, B. (1988). Experimental evaluation of surfactants for replacement therapy. Exp. Lung Res. 14, 279-310. doi: 10.3109/01902148809087810
141. Rocks, O., Peyker, A., Kahms, M., Verveer, P. J., Koerner, C., Lumbierres, M., et al. (2005). An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307, 1746-1752. doi: 10.1126/science.1105654
142. Roth, A. F., Wan, J., Bailey, A. O., Sun, B., Kuchar, J. A., Green, W. N., et al. (2006). Global analysis of protein palmitoylation in yeast. Cell 125, 1003-1013. doi: 10.1016/j.cell.2006.03.042
143. Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N. O., Leonova, J., et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 152, 1092-1101. doi: 10.1038/sj.bjp.0707460
144. Saadatian-Elahi, M., Norat, T., Goudable, J., and Riboli, E. (2004). Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int. J. Cancer 111, 584-591. doi: 10.1002/ijc.20284
145. Sahu, S., and Lynn, W. S. (1977). Lipid composition of airway secretions from patients with asthma and patients with cystic fibrosis. Am. Rev. Respir. Dis. 115, 233-239
146. Samovski, D., Sun, J., Pietka, T., Gross, R. W., Eckel, R. H., Su, X., et al. (2015). Regulation of AMPK activation by CD36 links fatty acid uptake to beta-oxidation. Diabetes 64, 353-359. doi: 10.2337/db14-0582
147. Schmid, P. C., Deli, E., and Schmid, H. H. (1995). Generation and remodeling of phospholipid molecular species in rat hepatocytes. Arch. Biochem. Biophys. 319, 168-176. doi: 10.1006/abbi.1995.1279
148. Schmidt, R., Meier, U., Yabut-Perez, M., Walmrath, D., Grimminger, F., Seeger, W., et al. (2001). Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am. J. Respir. Crit. Care Med. 163, 95-100. doi: 10.1164/ajrccm.163.1.9903029
149. Schwarz, J.-M., Neese, R. A., Tumer, S., Dare, D., and Hellerstein, M. K. (1995). Short-term alterations in carbohydrate energy intake in humans. striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J. Clin. Invest. 96:9. doi: 10.1172/JCI118342
150. Sette, S., Le Donne, C., Piccinelli, R., Arcella, D., Turrini, A., Leclercq, C., et al. (2011). The third Italian National Food Consumption Survey, INRAN-SCAI 2005-06-part 1: nutrient intakes in Italy. Nutr. Metab. Cardiovasc. Dis. 21, 922-932. doi: 10.1016/j.numecd.2010.03.001
151. Silbernagel, G., Kovarova, M., Cegan, A., Machann, J., Schick, F., Lehmann, R., et al. (2012). High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J. Clin. Endocrinol. Metab. 97, 5. doi: 10.1210/jc.2012-2152
152. Silvius, J. R. (1982). Thermotropic phase transitions of pure lipids in model membranes and their modifications by membrane proteins. Lipid Protein Interact. 2, 239-281
153. Simons, K., and Toomre, D. (2000). Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39. doi: 10.1038/35036052
154. Sinensky, M. (1974). Homeoviscous adaptation-a homeostatic process that regulates the viscosity of membrane lipids in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 71, 522-525. doi: 10.1073/pnas.71.2.522
155. Siri-Tarino, P. W., Sun, Q., Hu, F. B., and Krauss, R. M. (2010). Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr. Atheroscler. Rep. 12, 384-390. doi: 10.1007/s11883-010-0131-6
156. Skaper, S. D., Facci, L., Barbierato, M., Zusso, M., Bruschetta, G., Impellizzeri, D., et al. (2015). N-palmitoylethanolamine and neuroinflammation: a novel therapeutic strategy of resolution. Mol. Neurobiol. 52, 1034-1042. doi: 10.1007/s12035-015-9253-8
157. Smart, D., Jonsson, K. O., Vandevoorde, S., Lambert, D. M., and Fowler, C. J. (2002). 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J. Pharmacol. 136, 452-458. doi: 10.1038/sj.bjp.0704732
158. Song, X., Huang, Y., Neuhouser, M. L., Tinker, L. F., Vitolins, M. Z., Prentice, R. L., et al. (2017). Dietary long-chain fatty acids and carbohydrate biomarker evaluation in a controlled feeding study in participants from the Women's Health Initiative cohort. Am. J. Clin. Nutr. 105, 1272-1282. doi: 10.3945/ajcn.117.153072
159. Souza, C. O., Vannice, G. K., Neto, J. C. R., and Calder, P. C. (2017). Is palmitoleic acid a plausible non-pharmacological strategy to prevent or control chronic metabolic and inflammatory disorders? Mol. Nutr. Food Res. doi: 10.1002/mnfr.201700504. [Epub ahead of print]
160. Spiegelman, B. M., Choy, L., Hotamisligil, G. S., Graves, R. A., and Tontonoz, P. (1993). Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J. Biol. Chem. 268, 6823-6826
161. Stoeck, A., Shang, L., and Dempsey, P. J. (2010). Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J. Cell Sci. 123(Pt 13), 2319-2331. doi: 10.1242/jcs.060830
162. Strable, M. S., and Ntambi, J. M. (2010). Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit. Rev. Biochem. Mol. Biol. 45, 199-214. doi: 10.3109/10409231003667500
163. Sullivan, L. C., Orgeig, S., and Daniels, C. B. (2002). Control of the development of the pulmonary surfactant system in the saltwater crocodile, Crocodylus porosus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R1164-R1176. doi: 10.1152/ajpregu.00009.2002
164. Suresh, G. K., and Soll, R. F. (2001). Current surfactant use in premature infants. Clin. Perinatol. 28, 671-694. doi: 10.1016/S0095-5108(05)70112-3
165. Suri, L. N., McCaig, L., Picardi, M. V., Ospina, O. L., Veldhuizen, R. A., Staples, J. F., et al. (2012). Adaptation to low body temperature influences pulmonary surfactant composition thereby increasing fluidity while maintaining appropriately ordered membrane structure and surface activity. Biochim. Biophys. Acta 1818, 1581-1589. doi: 10.1016/j.bbamem.2012.02.021
166. Tappy, L., and Lê, K. A. (2010). Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 90, 23-46. doi: 10.1152/physrev.00019.2009
167. Thannhauser, S. J., Penotti, J., and Boncoddo, N. F. (1946). Isolation and properties of hydrolecithin (dipalmityl lecithin) from lung; its occurrence in the sphingomyelin fraction of animal tissues. J. Biol. Chem. 166, 669-675
168. Thorne, R. F., Ralston, K. J., de Bock, C. E., Mhaidat, N. M., Zhang, X. D., Boyd, A. W., et al. (2010). Palmitoylation of CD36/FAT regulates the rate of its post-transcriptional processing in the endoplasmic reticulum. Biochim. Biophys. Acta 1803, 1298-1307. doi: 10.1016/j.bbamcr.2010.07.002
169. Tian, L., McClafferty, H., Knaus, H. G., Ruth, P., and Shipston, M. J. (2012). Distinct acyl protein transferases and thioesterases control surface expression of calcium-activated potassium channels. J. Biol. Chem. 287, 14718-14725. doi: 10.1074/jbc.M111.335547
170. Tomassini Barbarossa, I., Carta, G., Murru, E., Melis, M., Zonza, A., Vacca, C., et al. (2013). Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals. Nutrition 29, 531-536. doi: 10.1016/j.nut.2012.09.018
171. Tsuboi, K., Ikematsu, N., Uyama, T., Deutsch, D. G., Tokumura, A., and Ueda, N. (2013). Biosynthetic pathways of bioactive N-acylethanolamines in brain. CNS Neurol. Disord. Drug Targets 12, 7-16. doi: 10.2174/1871527311312010005
172. Tsutsumi, R., Fukata, Y., and Fukata, M. (2008). Discovery of protein-palmitoylating enzymes. Pflugers Arch. 456, 1199-1206. doi: 10.1007/s00424-008-0465-x
173. Ueda, N., Tsuboi, K., and Uyama, T. (2010). N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog. Lipid Res. 49, 299-315. doi: 10.1016/j.plipres.2010.02.003
174. Ueda, N., Yamanaka, K., Katayama, K., Goparaju, S. K., Suzuki, H., and Yamamoto, S. (2001). Alkaline and acid amidases hydrolyzing anandamide and other N-acylethanolamines. World Rev. Nutr. Diet. 88, 215-222. doi: 10.1159/000059754
175. Uyeda, K., and Repa, J. J. (2006). Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4, 107-110. doi: 10.1016/j.cmet.2006.06.008
176. Vajreswari, A., and Narayanareddy, K. (1992). Effect of dietary fats on some membrane-bound enzyme activities, membrane lipid composition and fatty acid profiles of rat heart sarcolemma. Lipids 27, 339-343. doi: 10.1007/BF02536147
177. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. doi: 10.1126/science.1160809
178. Vander Heiden, M. G., Chandel, N. S., Schumacker, P. T., and Thompson, C. B. (1999). Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell 3, 159-167. doi: 10.1016/S1097-2765(00)80307-X
179. Van Golde, L. M., Batenburg, J. J., and Robertson, B. (1988). The pulmonary surfactant system: biochemical aspects and functional significance. Physiol. Rev. 68, 374-455
180. van Meer, G., Voelker, D. R., and Feigenson, G. W. (2008). Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124. doi: 10.1038/nrm2330
181. Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., and Longo, V. (2016). Targeting cancer metabolism: dietary and pharmacologic interventions. Cancer Discov. 6, 1315-1333. doi: 10.1158/2159-8290.CD-16-0615
182. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314. doi: 10.1126/science.123.3191.309
183. Weinhouse, S. (1976). The Warburg hypothesis fifty years later. Z. Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 87, 115-126. doi: 10.1007/BF00284370
184. Whitsett, J. A., Haitchi, H. M., and Maeda, Y. (2011). Intersections between pulmonary development and disease. Am. J. Respir. Crit. Care Med. 184, 401-406. doi: 10.1164/rccm.201103-0495PP
185. Wilke, M. S., French, M. A., Goh, Y. K., Ryan, E. A., Jones, P. J., and Clandinin, M. T. (2009). Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia 52, 1628-1637. doi: 10.1007/s00125-009-1405-9
186. Winder, W. W., and Hardie, D. G. (1999). AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277(1 Pt 1), E1-E10
187. Wustneck, R., Perez-Gil, J., Wustneck, N., Cruz, A., Fainerman, V. B., and Pison, U. (2005). Interfacial properties of pulmonary surfactant layers. Adv. Colloid Interface Sci. 117, 33-58. doi: 10.1016/j.cis.2005.05.001
188. Yang, W., Di Vizio, D., Kirchner, M., Steen, H., and Freeman, M. R. (2010). Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol. Cell. Proteomics 9, 54-70. doi: 10.1074/mcp.M800448-MCP200
189. Yang, X., Guo, Z., Sun, F., Li, W., Alfano, A., Shimelis, H., et al. (2011). Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells. J. Biol. Chem. 286, 36152-36160. doi: 10.1074/jbc.M111.265124
190. Yu, S. H., and Possmayer, F. (1988). Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Biochim. Biophys. Acta 961, 337-350. doi: 10.1016/0005-2760(88)90081-1
191. Zheng, H., Pearsall, E. A., Hurst, D. P., Zhang, Y., Chu, J., Zhou, Y., et al. (2012). Palmitoylation and membrane cholesterol stabilize mu-opioid receptor homodimerization and G protein coupling. BMC Cell Biol. 13:6. doi: 10.1186/1471-2121-13-6
192. Zolese, G., Falcioni, G., Bertoli, E., Galeazzi, R., Wozniak, M., Wypych, Z., et al. (2000). Steady-state and time resolved fluorescence of albumins interacting with N-oleylethanolamine, a component of the endogenous N-acylethanolamines. Proteins 40, 39-48. doi: 10.1002/(SICI)1097-0134(20000701)40:1<39::AID-PROT60>3.0.CO;2-N
193. Zygmunt, P. M., Ermund, A., Movahed, P., Andersson, D. A., Simonsen, C., Jönsson, B. A., et al. (2013). Monoacylglycerols activate TRPV1-a link between phospholipase C and TRPV1. PLoS ONE 8:e81618. doi: 10.1371/journal.pone.0081618
194. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sørgård, M., Di Marzo, V., et al. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457. doi: 10.1038/22761